Literature DB >> 8454916

Newly established human pancreatic carcinoma cell lines and their lectin binding properties.

N Nishimura1, S Saito, Y Kubota, N Moto-o, K Taguchi, K Yamazaki, A Watanabe, H Sasaki.   

Abstract

Two human pancreatic carcinoma cell lines, designated HuP-T3 and HuP-T4, were established from the ascites of pancreatic cancer patients with carcinomatous peritonitis. The cell lines were grown in monolayer cultures and had population doubling times of 38.6 and 37.1 h, respectively. HuP-T4 secreted large amounts of CEA and CA19-9 into the medium, and HuP-T3 produced a small amount of CEA, but no CA19-9. Both cell lines showed tumorigenicity in nude mice. Histologically, the HuP-T3-derived tumor was poorly differentiated adenocarcinoma, and the HuP-T4-derived tumor was well differentiated papillotubular adenocarcinoma. In lectin histochemistry at both light and electron microscopic levels, the most striking difference between the lectin binding properties of the two cell lines and those of control normal pancreatic ductal cells was that soybean agglutinin (SBA) bound to both cell lines, but not to controls. These newly established cell lines should be useful models that will contribute to clarifying the biological and biochemical characteristics of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454916     DOI: 10.1007/bf02795197

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  15 in total

1.  Structural basis for altered soybean agglutinin lectin binding between a murine metastatic lymphoma and an adhesive low malignant variant.

Authors:  E Lang; U Kohl; V Schirrmacher; R Brossmer; P Altevogt
Journal:  Exp Cell Res       Date:  1987-11       Impact factor: 3.905

2.  A histochemical study of mucins in normal and neoplastic human pancreatic tissue.

Authors:  P F Roberts; J Burns
Journal:  J Pathol       Date:  1972-06       Impact factor: 7.996

3.  Lectin-binding sites in clear cell acanthoma.

Authors:  M Akiyama; K Hayakawa; Y Watanabe; T Nishikawa
Journal:  J Cutan Pathol       Date:  1990-08       Impact factor: 1.587

4.  Lectin-defined cell surface glycoconjugates of pancreatic cancer cells and their nonmalignant counterparts.

Authors:  A Raedler; W H Schmiegel; E Raedler; R Arndt; H G Thiele
Journal:  Exp Cell Biol       Date:  1983

5.  Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation.

Authors:  C R Boland; C K Montgomery; Y S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging.

Authors:  M Mumcuoglu; M Favrot; S Slavin
Journal:  Exp Hematol       Date:  1990-01       Impact factor: 3.084

7.  Lectin binding to human gastric adenocarcinomas and adjacent tissues.

Authors:  M Bur; W A Franklin
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

8.  Use of lectin histochemistry in pancreatic cancer.

Authors:  C K Ching; R Black; T Helliwell; A Savage; H Barr; J M Rhodes
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

9.  Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow.

Authors:  S Morecki; S Margel; S Slavin
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

10.  Expression of fetoacinar pancreatic (FAP) protein in the pancreatic human tumor cell line BxPC-3.

Authors:  A Mazo; Y Fujii; J Shimotake; M J Escribano
Journal:  Pancreas       Date:  1991-01       Impact factor: 3.327

View more
  2 in total

1.  Characterization of lectins and their specificity in carcinomas-An appraisal.

Authors:  Asma Farhat Sherwani; Sameena Mohmood; Fauzia Khan; Rizwan Hasan Khan; Md Asim Azfer
Journal:  Indian J Clin Biochem       Date:  2003-07

2.  Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.

Authors:  Arkadeep Sinha; David Cherba; Heather Bartlam; Elizabeth Lenkiewicz; Lisa Evers; Michael T Barrett; Brian B Haab
Journal:  Mol Oncol       Date:  2014-05-02       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.